Anti‐vascular endothelial growth factor for prevention of postoperative vitreous cavity haemorrhage after vitrectomy for proliferative diabetic retinopathy

JM Smith, DHW Steel - Cochrane Database of Systematic …, 2015 - cochranelibrary.com
Background Postoperative vitreous cavity haemorrhage (POVCH) is a significant
complication following vitrectomy for proliferative diabetic retinopathy (PDR). It delays visual …

Perioperative anti-vascular endothelial growth factor agents treatment in patients undergoing vitrectomy for complicated proliferative diabetic retinopathy: a network …

D Wang, X Zhao, W Zhang, L Meng, Y Chen - Scientific Reports, 2020 - nature.com
Currently, controversies regarding the optimal time-point of anti-vascular endothelial growth
factor (VEGF) pretreatment before pars plana vitrectomy (PPV) for proliferative diabetic …

Intraocular VEGF level as a risk factor for postoperative complications after vitrectomy for proliferative diabetic retinopathy

Y Wakabayashi, Y Usui, Y Okunuki… - … & visual science, 2012 - iovs.arvojournals.org
Purpose.: To investigate whether vitreous and aqueous humor concentrations of vascular
endothelial growth factor (VEGF) predict postoperative complications after vitrectomy for …

Comparison of microinsicion vitrectomy and conventional 20-gauge vitrectomy for severe proliferative diabetic retinopathy

R Yokota, M Inoue, Y Itoh, T Rii, K Hirota… - Japanese journal of …, 2015 - Springer
Purpose To compare the outcomes of 23-gauge (G) and 25G vitrectomy to 20G vitrectomy
on eyes with severe proliferative diabetic retinopathy (PDR). Methods The medical records …

The effect of adjunctive intravitreal conbercept at the end of diabetic vitrectomy for the prevention of post-vitrectomy hemorrhage in patients with severe proliferative …

T Jiang, J Gu, P Zhang, W Chen, Q Chang - BMC ophthalmology, 2020 - Springer
Background To investigate the effect of intravitreal conbercept (IVC) injections on the
incidence of postoperative vitreous hemorrhage (VH) in eyes undergoing surgery for severe …

Persistent overproduction of intraocular vascular endothelial growth factor as a cause of late vitreous hemorrhage after vitrectomy for proliferative diabetic retinopathy

Y Wakabayashi, Y Usui, K Tsubota, S Ueda… - Retina, 2017 - journals.lww.com
Purpose: The purpose of this study was to investigate whether vitreous levels of vascular
endothelial growth factor (VEGF) predict late vitreous hemorrhage (VH) after vitrectomy for …

Entry site treatment to prevent late recurrent postoperative vitreous cavity haemorrhage after vitrectomy for proliferative diabetic retinopathy

DHW Steel, A Connor, MS Habib… - British Journal of …, 2010 - bjo.bmj.com
Aims To assess the effectiveness of treatment to the inner sclerostomy sites at the time of
vitrectomy for proliferative diabetic retinopathy (PDR) in reducing the incidence of late …

Intravitreal bevacizumab injection for recurrent vitreous haemorrhage after diabetic vitrectomy

PT Yeh, CH Yang, CM Yang - Acta ophthalmologica, 2011 - Wiley Online Library
Purpose: To evaluate the efficacy of intravitreal bevacizumab in treating recurrent vitreous
haemorrhage (VH) after diabetic vitrectomy. Methods: Consecutive patients with …

Intravitreal conbercept injection as an adjuvant in vitrectomy with silicone oil infusion for severe proliferative diabetic retinopathy

S Gao, Z Lin, Y Chen, J Xu, Q Zhang… - Journal of Ocular …, 2020 - liebertpub.com
Purpose: To assess the clinical effects of preoperative, intraoperative, or preoperative
combined with intraoperative intravitreal conbercept (IVC) injection in vitrectomy with …

Intravitreal bevacizumab for postoperative recurrent vitreous hemorrhage after vitrectomy for proliferative diabetic retinopathy

K Ferenchak, R Duval, JA Cohen, MW MacCumber - Retina, 2014 - journals.lww.com
Purpose: To describe the experience of authors using intravitreal bevacizumab (IVB) for
eyes with recurrent vitreous hemorrhage (VH) after vitrectomy for proliferative diabetic …